Table 1.
Sample characteristics (N=1,293)
| Sample characteristic | Unweighted | Weighted | ||||
|---|---|---|---|---|---|---|
| Mean | S.E. | % | Mean | S.E. | % | |
| PCIE | 0.1 | 0.0 | 0.0 | 0.0 | ||
| Baseline cancer-related problem index | 2.5 | 0.1 | 2.3 | 0.1 | ||
| Follow-up cancer-related problem index | 2.1 | 0.6 | 1.9 | 0.6 | ||
| Age | 65.5 | 0.3 | 67.8 | 0.5 | ||
| Female | 51.4 | 51.2 | ||||
| Education | ||||||
| High school and below | 52.4 | 51.7 | ||||
| Some college and above | 47.6 | 48.3 | ||||
| Race/ ethnicity | ||||||
| White | 86.2 | 88.1 | ||||
| Black | 10.4 | 8.4 | ||||
| Hispanic or other | 3.4 | 3.4 | ||||
| Worry at diagnosis | 3.73 | 0.05 | 3.60 | 0.05 | ||
| Non-medical seeking | 0.1 | 0.0 | 0.0 | 0.0 | ||
| Cancer type | ||||||
| Colon | 31.9 | 31.5 | ||||
| Breast | 34.8 | 35.0 | ||||
| Prostate | 33.3 | 33.5 | ||||
| Cancer stage | ||||||
| Stage 0 | 9.0 | 12.2 | ||||
| Stage 1 | 20.2 | 19.6 | ||||
| Stage 2 | 44.7 | 46.6 | ||||
| Stage 3 | 13.0 | 12.1 | ||||
| Stage 4 | 13.2 | 9.5 | ||||
| Treatment received | ||||||
| Surgery | 73.3 | 72.7 | ||||
| Radiation therapy | 48.4 | 49.3 | ||||
| Systemic therapy | 56.5 | 51.7 | ||||
| Health status | 3.2 | 0.0 | 3.2 | 0.0 | ||
| Frequency of doctor visits | 3.6 | 0.0 | 3.5 | 0.0 | ||
| Cancer experience | 3.6 | 0.0 | 3.7 | 0.0 | ||
| Informed of metastatic disease | 14.3 | 11.7 | ||||